Posts by John

Belenos Biosciences hits key milestones with positive Phase 2 results for BEL512 in treating chronic rhinosinusitis and nasal polyps. Read the latest update.

A new Phase 2 trial reveals that divesiran shows significant clinical promise in treating polycythemia vera by reducing the need for phlebotomy.

UCLA researchers receive $1.2M to test if common diabetes medications can stop the growth of early-stage lung cancer cells. Learn about this medical breakthrough.

Nitinotes expands its EASE™ IDE clinical trial to Weill Cornell Medicine to evaluate a novel, minimally invasive endoscopic weight-loss procedure.

As a new Ebola clinical trial launches in the DRC, experts address three key questions regarding treatment efficacy, safety, and logistical distribution.

Campbell University bridges the gap between pharmaceutical science and clinical research with a new degree designed for the future of drug development.

A recent clinical trial explores whether psilocybin-assisted therapy can help patients with anorexia overcome cognitive rigidity and seek recovery.

Discover how a transparent, data-driven approach is transforming vaccine trial recruitment to improve subject diversity and boost clinical trial efficacy.

Scholar Rock’s apitegromab filing highlights critical risks in CMO due diligence. Learn why proactive manufacturer oversight is essential for clinical success.

AI in drug discovery is racing to Phase I, but experts argue true success lies in late-stage results. Learn why clinical efficacy is the real goal.